` Comparison: X2S vs 0HF3 - Alpha Spread

X2S
vs
A
0HF3

Over the past 12 months, X2S has outperformed 0HF3, delivering a return of +15% compared to the 0HF3's +12% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
X2S
0HF3
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

X2S Intrinsic Value
9.902 EUR
Undervaluation 76%
Intrinsic Value
Price €2.329
A
0HF3 Intrinsic Value
502.14 USD
Undervaluation 36%
Intrinsic Value
Price $320.28
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Sinopharm Group Co Ltd
F:X2S
2.329 EUR
A
Amerisourcebergen Corp
LSE:0HF3
320.28 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
X2S, 0HF3

X2S
0HF3
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Sinopharm Group Co Ltd
Revenue
A
Amerisourcebergen Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
X2S, 0HF3

X2S
0HF3
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Sinopharm Group Co Ltd
F:X2S
A
Amerisourcebergen Corp
LSE:0HF3
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

X2S
7.2%
0HF3
3.6%

Operating Margin

X2S
2.8%
0HF3
1.2%

Net Margin

X2S
1.2%
0HF3
0.5%

FCF Margin

X2S
3%
0HF3
1.1%

ROE

X2S
8.8%
0HF3
152.3%

ROA

X2S
1.8%
0HF3
2.2%

ROIC

X2S
6.2%
0HF3
15.2%

ROCE

X2S
11.2%
0HF3
23.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
X2S, 0HF3

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
X2S, 0HF3

Loading
X2S
0HF3
Difference
www.alphaspread.com

Performance By Year
X2S, 0HF3

Loading
X2S
0HF3
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare X2S to other stocks
MCK
Mckesson Corp
More expensive
vs X2S
COR
Cencora Inc
More expensive
vs X2S
CAH
Cardinal Health Inc
More expensive
vs X2S
SIG
Sigma Healthcare Ltd
More expensive
vs X2S
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett